Department of Anesthesia, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA.
Eur J Cardiothorac Surg. 2010 Dec;38(6):741-4. doi: 10.1016/j.ejcts.2010.03.029.
This study was undertaken to compare the effect of deep hypothermic circulatory arrest, compared with moderate hypothermia, on the plasma concentrations and pharmacokinetic profile of vancomycin, administered as prophylaxis, in patients undergoing cardiac surgery with cardiopulmonary bypass.
Two groups of adult cardiac surgery patients were prospectively studied. One group consisted of 12 patients undergoing valvular surgery with moderate hypothermia, and another group was of 12 patients undergoing surgery with the use of profound hypothermic circulatory arrest. Vancomycin was administered before skin incision, and plasma levels were measured at regular intervals for 24h.
The plasma concentrations of vancomycin showed a similar pattern in both groups. The pharmacokinetic profile showed a three-compartment model in both groups.
The dosing of vancomycin, if used as antibiotic prophylaxis, does not need to be adjusted in cardiac surgery patients when undergoing profound hypothermic circulatory arrest, since the plasma concentrations and pharmacokinetic profile are similar to patients with moderate hypothermia. The pharmacokinetic profile, consisting of three compartments, was not changed by the differences in temperature.
本研究旨在比较深低温停循环与中度低温对体外循环心脏手术患者预防性应用万古霉素的血浆浓度和药代动力学特征的影响。
前瞻性研究了两组成人心脏手术患者。一组 12 例患者行瓣膜手术,采用中度低温;另一组 12 例患者行深低温停循环手术。万古霉素于切开皮肤前给药,在 24 小时内定期测量血浆水平。
两组患者的万古霉素血浆浓度均呈相似模式。药代动力学特征显示两组均为三室模型。
如果深低温停循环心脏手术患者预防性应用万古霉素,不需要调整剂量,因为其血浆浓度和药代动力学特征与中度低温患者相似。由温度差异引起的药代动力学特征(包括三个隔室)未发生变化。